Bristol-Myers Squibb (BMY) to Acquire Celgene Corp. (CELG) for Approx. $74B

January 3, 2019 6:59 AM
Bristol-Myers Squibb Company (NYSE: BMY) and Celgene Corporation (NASDAQ: CELG) today announced that they have entered into a definitive merger ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Hot M&A Management Comments Mergers and Acquisitions

Next Articles